SYRACUSE — Barclay Damon recently announced that Christina Verone Juliano, partner, has joined the law firm’s health-care controversies team, based in its Syracuse office. She is also part of the firm’s commercial litigation & complex trials and torts & products-liability defense practice areas. With more than 15 years of experience trying cases in both state […]
SYRACUSE — Barclay Damon recently announced that Christina Verone Juliano, partner, has joined the law firm’s health-care controversies team, based in its Syracuse office.
She is also part of the firm’s commercial litigation & complex trials and torts & products-liability defense practice areas.
With more than 15 years of experience trying cases in both state and federal courts, Verone Juliano represents a wide range of health-care clients in civil matters including commercial disputes, asbestos and toxic tort litigation, environmental litigation, employment litigation, product liability, personal injury and general-insurance defense, medical malpractice, and management and professional-liability matters.
“Christina’s considerable experience with health-care litigation adds significant depth to the firm’s well-established bench of health-care practice group attorneys,” Chris Greene, Barclay Damon’s health-care practice group leader, said in a statement. “Not only is Christina a highly skilled litigator, she has an undeniable ability to connect with her clients and put them at ease.”
Verone Juliano said she is excited to join what she calls a team of “powerhouse health-care litigators.” She stated, “I’m honored to join their ranks and am looking forward to helping the firm grow and offer more services to health-care clients in Syracuse and beyond. I’m also looking forward to collaborating with my new colleagues in other practice areas throughout the firm’s platform of offices.”
Barclay Damon has nearly 300 attorneys across offices in Albany, Buffalo, New York City, Rochester, and Syracuse, in New York state, as well as Boston, Massachusetts; New Haven, Connecticut; Washington, D.C.; and Toronto, Canada.
